Focus: Infection Control

Study finds most endoscopes contain bacterial growth after reprocessing

Studies suggest current reprocessing methods are ineffective


Two recent studies suggest that current reprocessing methods do not effectively sterilize flexible endoscopes, according to an article on the Becker's Clinical Leadership & Infection Control website.

In a study in the American Journal of Infection Control, researchers found that 22 percent of endoscopes had signs of organic contamination and 71 percent still contained microbial growth after reprocessing.

The researchers took samples of fully reprocessed endoscopes stored for at least 24 hours.

Researchers in the Netherlands found at least one reprocessed duodenoscope contaminated with detectable microbes in 39 percent of all Dutch healthcare facilities studied.

Read the article.

 

 



May 3, 2018


Topic Area: Infection Control


Recent Posts

How Architects Shape the Future of Healthcare Facilities

Healthcare architecture is more than just designing and building hospitals.


UNC Health, Duke Health Form Partnership for Stand-alone Children's Hospital

The partners plan to break ground together on the new NC Children’s campus by 2027.


Sarasota Memorial Hospital Plans to Build New Facility in North Port

The six-story, 100-bed hospital is slated to open in fall of 2028.


CMMS, Data and the Path to Compliance

Taking control of healthcare facilities data in CMMS enables managers to use it to ensure the efficient operation and maintenance of their assets.


Healthcare is a Major Ransomware Target

Healthcare is the third-most-targeted sector, according to the report.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.